CRIS Current Research Information System

DE LORENZO, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.873
EU - Europa 1.499
AS - Asia 506
AF - Africa 107
SA - Sud America 11
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.999
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.855
IT - Italia 367
SE - Svezia 285
GB - Regno Unito 280
VN - Vietnam 205
DE - Germania 163
CN - Cina 120
IE - Irlanda 98
CH - Svizzera 86
IN - India 81
FR - Francia 39
RU - Federazione Russa 38
SG - Singapore 38
TG - Togo 38
CI - Costa d'Avorio 29
JO - Giordania 27
UA - Ucraina 22
BG - Bulgaria 21
ZA - Sudafrica 19
EE - Estonia 18
NG - Nigeria 17
BE - Belgio 13
CA - Canada 13
FI - Finlandia 13
GR - Grecia 13
AT - Austria 12
TR - Turchia 9
PS - Palestinian Territory 8
KR - Corea 6
NL - Olanda 6
PL - Polonia 6
CL - Cile 4
ES - Italia 4
NI - Nicaragua 4
RO - Romania 4
BR - Brasile 3
HR - Croazia 3
SC - Seychelles 3
UZ - Uzbekistan 3
AR - Argentina 2
IR - Iran 2
LB - Libano 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EG - Egitto 1
HK - Hong Kong 1
HU - Ungheria 1
JP - Giappone 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 3.999
Salva come PNG Salva come JPEG
Città #
Southend 255
Chandler 238
Fairfield 225
Dong Ket 162
Ashburn 134
Woodbridge 128
Houston 120
Wilmington 100
Dublin 98
Seattle 92
Bern 82
Princeton 82
Cambridge 77
Ann Arbor 75
Bologna 71
Lomé 38
Turin 35
New York 32
Singapore 32
Abidjan 29
Nanjing 29
Beijing 28
Berlin 28
Amman 27
Westminster 23
Milan 22
San Diego 21
Sofia 21
Redmond 18
Abeokuta 17
Padova 15
Frankfurt am Main 14
Helsinki 13
Brussels 12
Ravenna 11
Redwood City 11
Florence 10
Rome 10
Shenyang 10
Toronto 10
Vienna 10
Des Moines 9
Olalla 9
Bremen 8
Halhul 8
Saint Petersburg 8
Jacksonville 7
Medford 7
Norwalk 7
Torino 7
Boardman 6
Hebei 6
Istanbul 6
Jinan 6
London 6
Los Angeles 5
Mountain View 5
Nanchang 5
Pune 5
Zhengzhou 5
Bühl 4
Changsha 4
Chicago 4
Forlì 4
Hefei 4
Jiaxing 4
Leawood 4
Managua 4
Monmouth Junction 4
Napoli 4
Parma 4
San Mateo 4
Warsaw 4
Athens 3
Casalecchio Di Reno 3
Cesena 3
Haikou 3
Mahé 3
Moscow 3
Paris 3
São Paulo 3
Washington 3
Alexandria 2
Amsterdam 2
Auckland 2
Bari 2
Cernobbio 2
Cinisello Balsamo 2
Den Haag 2
Empoli 2
Esslingen am Neckar 2
Falls Church 2
Fremont 2
Fulham 2
Galliera 2
Genoa 2
Guangzhou 2
Hangzhou 2
Hyderabad 2
Kuban 2
Totale 2.705
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 233
Adjuvant treatment in biliary tract cancer 192
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 177
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 159
Fulminant hepatitis in a patient with hepatocellular carcinoma related to nonalcoholic steatohepatitis treated with sorafenib. 153
Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis 151
An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI alone 150
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention 147
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 138
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 135
Cholangiocarcinoma: From risk to prevention? 134
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 132
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept 123
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 117
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib 112
Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report 112
In Reply 111
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation. 108
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 104
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 103
Adjuvant Treatment and Follow-up Strategies 96
Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report. 86
Treatment of combined hepatocellular and cholangiocarcinoma 81
Regorafenib for the treatment of hepatocellular carcinoma 79
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 79
null 75
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster 68
How to choose between percutaneous transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: An updated systematic review and meta-analysis 66
Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases? 65
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 61
Immunotherapy with checkpoint inhibitors for hepatocellular carcinoma: Where are we now? 60
Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its prognostic role 60
Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis 58
null 56
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 53
Second-line treatment in advanced biliary tract cancer: Today and tomorrow 49
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 48
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma 40
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma 30
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 30
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 29
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 27
Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development 25
Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016 24
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma 20
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials 19
Microbiota, NASH, HCC and the potential role of probiotics 15
Should patients on levothyroxine therapy be screened for pancreatic cancer? 4
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain? 4
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis 3
Totale 4.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020636 0 23 5 32 81 69 92 105 104 55 41 29
2020/2021678 74 30 17 12 72 54 36 46 69 41 28 199
2021/2022961 112 46 46 64 74 29 30 67 84 61 219 129
2022/20231.180 114 169 56 115 84 77 46 68 207 58 60 126
2023/2024327 34 51 16 28 16 69 13 19 17 26 21 17
2024/202573 68 5 0 0 0 0 0 0 0 0 0 0
Totale 4.201